Maze Therapeutics MAZE
NASDAQ MAZE
$32.68 +0.23 (+0.71%)
As of: Oct 21, 2026 · 11:03 AM EDT

Maze Therapeutics (MAZE) Non-Current Debt (2026)

Updated

Maze Therapeutics' Non-Current Debt came in at $38.96 million for Q2 2026, up 0.3% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Non-Current Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn 62.48 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 60.50 Bn
10 Maze Therapeutics 1.93 Bn 439.26 Mn - 38.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.96 Mn
Mar 31, 2026 38.83 Mn
API Access

Maze Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MAZE&period=max&api_key=YOUR_API_KEY